Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_001164161.2(PPP6R3):c.736G>A(p.Glu246Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
PPP6R3 (HGNC:1173): (protein phosphatase 6 regulatory subunit 3) Protein phosphatase regulatory subunits, such as SAPS3, modulate the activity of protein phosphatase catalytic subunits by restricting substrate specificity, recruiting substrates, and determining the intracellular localization of the holoenzyme. SAPS3 is a regulatory subunit for the protein phosphatase-6 catalytic subunit (PPP6C; MIM 612725) (Stefansson and Brautigan, 2006 [PubMed 16769727]).[supplied by OMIM, Nov 2010]
Review Status: criteria provided, single submitter
Collection Method: clinical testing
The c.736G>A (p.E246K) alteration is located in exon 8 (coding exon 6) of the PPP6R3 gene. This alteration results from a G to A substitution at nucleotide position 736, causing the glutamic acid (E) at amino acid position 246 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Gain of methylation at E246 (P = 0.0087);Gain of methylation at E246 (P = 0.0087);Gain of methylation at E246 (P = 0.0087);Gain of methylation at E246 (P = 0.0087);Gain of methylation at E246 (P = 0.0087);Gain of methylation at E246 (P = 0.0087);Gain of methylation at E246 (P = 0.0087);Gain of methylation at E246 (P = 0.0087);